Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$17.9M
8M shares
52-week range
$1.72 – $23.10
2% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Modular Medical Inc is a development stage medical device company which focuses on the design, development, marketing and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.
www.modular-medical.comNo one on the platform currently holds MODD.
No tracked institution reports a position in MODD as of their last filing.
| Execution date | Ratio |
|---|---|
| 2026-03-31 | 1-for-30reverse |
| 2021-11-29 | 1-for-3reverse |
No one on the platform has traded MODD yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $35M | +996.9% | $-17.10 | $-17.10–$-17.10 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-06-29 | $-2.70 | $-1.37 | +49.3% |
| 2026-02-17 | $-3.00 | $-3.30 | -10.0% |
| 2025-11-14 | $-0.10 | $-0.14 | -40.0% |
| 2025-08-14 | $-0.10 | $-0.12 | -20.0% |
| 2025-06-20 | $-0.11 | $-0.12 | -9.1% |
| 2025-02-13 | $-0.12 | $-0.13 | -8.3% |
| 2024-11-14 | $-0.14 | $-0.14 | +0.0% |
| $20M |
| — |
| IINNInspira Technologies OXY B.H.N. Ltd. | $1.05 | -0.94% | $25M | — |
| INTSIntensity Therapeutics, Inc. | $4.11 | +5.93% | $11M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$MODD getting cold in the mornings here in Winnipeg...gotta start the winter prep this weekend. Anyone wanna help chop a few cords of firewood? 🪵🪓
View on StockTwits ↗$MODD As to why Jeb and board continue down this road to perdition, I’ve expressed a couple of theories. The darker possibility is that absolutely no one wants to own this pump.
View on StockTwits ↗$MODD A third one is CeQur, for reasons I’ve explained. If they add an easy-to-use pump, they have something to offer their patients wanting a pump.
View on StockTwits ↗$MODD Another possibility might be a Chinese company such as Medtrum or MicroTech Medical. The big US players always have the patent card to play, but Modular uses an entirely different configuration. Again, seems like a no-brainer.
View on StockTwits ↗$MODD Another interesting player might be the Ypsomed spin-off, which is called MyLife. It’s run by the son of Ypsomed’s billionaire founder. They have an FDA approved algorithm, CamAPS FX, but no pump. Seems like a no-brainer, especially since Ypsomed is building a giant new injectable facility in North Carolina.
View on StockTwits ↗$MODD when we hit 21.00....thats a straight up 10x from here. Besides the pre-funded warrants, the next price for the warrants is around $20, jeb said....sounds like outstanding shares + warrants puts us at around 11m shares...jeb sounds like he would totally be on board for a partnership or buyout....and so would I. See you all Monday...oct 1 is next payday...loading... Currently at 9500 shares....we break 10k shares oct 1.
View on StockTwits ↗$MODD jist gave that conference call another listen. Sounds incredibly realistic and long term very bullish. One more day of work and then 5 days off. 🥵🥱.....📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈📈⏰️
View on StockTwits ↗$MODD looks like market doesnt care about anything but showing revenue on the balance sheet....more time to load.
View on StockTwits ↗$MODD presentation replay is now available. Access the replay: https://www.webcaster5.com/Webcast/Page/3171/54465 #microcap #smallcap #investing
View on StockTwits ↗$MODD Beta and Tandem just raised. Insulet is always flush. Minimed is riding high and likely to raise. Sequel is backed by billionaires. Mylife has an FDA approved algo, but no US pump ATM.
View on StockTwits ↗$MODD @deepthinker you were saying this last time the stock went this low Chill bro I think this dude is an AI bot. Explains why he never responds
View on StockTwits ↗$MODD See, this pump is valued at $20 million. Pumps are commodity items in 2026, even patch pumps. They’re almost like vacuum cleaners or microwave ovens. The differences between them are minor. It’s all in the marketing and distribution. Modular has no distribution, and they don’t have the money to create any. Their only hope is that someone else will see some value in acquiring them. I don’t know who that might be, but someone with existing distribution most likely, or an overseas company looking for an easy entry to the US market.
View on StockTwits ↗$MODD Jeb is going through the motions with these pitches, but I don’t think it’s real. The math on “going-it-alone” don’t math. They’’d end up delisted. I think they’ve done a deal of some kind.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.